Back to search

Article

AI enabled exome and transcriptome liquid biopsy platform spanning the continuum of care in oncology

2025-05-28

Abstract excerpt

<h4>Structured Abstract</h4> <h4>Background</h4> Effective clinical management of patients with cancer requires highly accurate diagnosis, precise therapy selection, and highly sensitive monitoring of disease burden. Caris Assure is a multifunctional blood-based assay that couples whole exome and whole transcriptome sequencing on plasma and leukocytes with advanced machine learning techniques to satisfy all three...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
23d4f853-8e9d-5e55-8c00-d35f95975625
DOI
10.1101/2025.05.23.25328255
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
AI enabled exome and transcriptome liquid biopsy platform spanning the continuum of care in oncologyDOI 10.1101/2025.05.23.25328255
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsSemantic proximity
Clinical Development of Molecular Residual Disease (MRD) and Multi-Cancer Early Detection (MCED) using Liquid Biopsy Multiomics with Artificial Intelligence (AI)Semantic proximity
Liquid biopsies across the cancer care continuum.Semantic proximity
Clinical and analytical validation of MI Cancer Seek®, a companion diagnostic whole exome and whole transcriptome sequencing-based comprehensive molecular profiling assaySemantic proximity
Bridging Discovery and Treatment: Cancer BiomarkerSemantic proximity
Characterization of Plasma Cell-Free DNA Variants as of Tumor or Clonal Hematopoiesis Origin in 16,812 Advanced Cancer PatientsSemantic proximity
From Genomics to AI: Revolutionizing Precision Medicine in OncologySemantic proximity
Analytical validation and clinical utilization of K-4CARE<sup>TM</sup>: a comprehensive genomic profiling assay with personalized MRD detectionSemantic proximity
Clinical application of tumour whole genome sequencing in routine molecular diagnostics for solid cancer patientsSemantic proximity
A prospective national precision medicine trial comparing blood and tissue profiling in patients with Cancer of Unknown Primary (CUPCOMP)Semantic proximity
A liquid biopsy-centered, pan-cancer, open next generation sequencing panel to support clinical decision-making (LION panel)Semantic proximity
Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application.Semantic proximity
Select a neighboring publication to make it the new centre.